Novel MEI1 compound heterozygous mutation in a sporadic family associated with spermatogenetic failure
Asian Journal of Andrology · 2023-07 · 25 (4) · 544-546
DOI: 10.4103/aja202280 ↗Kurz gefasst
Leserbrief in der Zeitschrift Asian Journal of Andrology, online erschienen am 01.11.2022. Verfasst von Jie Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine Center, Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, China. Hauptthemen laut MEDLINE: Cell Cycle Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Reproductive Medicine Center, Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, China.
- Yinfeng Gene Technology Co., Ltd., Jinan 250000, China.
Zitieren
APA
Chen, J., Li, F. H., Zhang, X. B., Du, Z. L., Jin, Y. S., Cui, Y. Q., & Wang, X. (2023). Novel MEI1 compound heterozygous mutation in a sporadic family associated with spermatogenetic failure. Asian Journal of Andrology, 25(4), 544-546. https://doi.org/10.4103/aja202280
Vancouver
Chen J, Li FH, Zhang XB, Du ZL, Jin YS, Cui YQ, et al. Novel MEI1 compound heterozygous mutation in a sporadic family associated with spermatogenetic failure. Asian Journal of Andrology. 2023;25(4):544-546. doi:10.4103/aja202280
BibTeX
@article{Chen2023,
author = {Chen, Jie and Li, Feng-Hua and Zhang, Xue-Bao and Du, Zhao-Li and Jin, Yin-Shan and Cui, Yuan-Qing and Wang, Xiong},
title = {Novel MEI1 compound heterozygous mutation in a sporadic family associated with spermatogenetic failure},
journal = {Asian Journal of Andrology},
year = {2023},
volume = {25},
number = {4},
pages = {544--546},
doi = {10.4103/aja202280}
}
EUVIMED